Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Maternal-Fetal and Obstetric Evidence Based Guidelines, Two Volume Set, 4th Edition
Berghella
Editore
CRC
Anno
2022
Pagine
1019
ISBN
9780367567033
215,00 €
Designed for easy revision of the key points, key references, and key management stages, the two volumes in this set review the evidence for best practice, presenting the reader with the right information, in the right format, summarized in easy-to-use tables and algorithms. Each guideline is designed to "make it easy to do it right", with appropriate use of proven interventions. The quality of evidence available is graded so that a well-informed clinician can improve the health of mother and baby by providing quality care. *Offers an easy-to-assimilate guide to the key points in maternal-fetal and obstetric practice *Supplies an invaluable resource for those revising topics for professional or clinical requirements *Ensures providers of care can locate the best intervention quickly and confidently
Vincenzo Berghella is Director, Division of Maternal-Fetal Medicine, at Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA. A former President of the Society for Maternal-Fetal Medicine, he is Editor-in-Chief and founder for American Journal of Obstetrics & Gynecology MFM; also works on the editorial team for Journal of Maternal Fetal & Neonatal Medicine, British Journal of Obstetrics & Gynecology, and the Cochrane Review; he is Oral Examiner for American Board of Obstetrics and Gynecology: Maternal-Fetal Medicine.
MATERNAL FETAL: Hypertensive disorders. Cardiac disease. Obesity. Pregestational diabetes. Gestational diabetes. Hypothyroidism. Hyperthyroidism. Prolactinoma. Nausea/vomiting of pregnancy and hyperemesis gravidarum. Intrahepatic cholestasis of pregnancy. Inflammatory bowel disease. Gallbladder disease. Pregnancy after liver and other transplantation. Maternal anemia. Sickle cell disease. von Willebrand disease. Renal disease. Headache. Seizures. Spinal cord injury. Mood disorders. Smoking. Drug abuse. Respiratory diseases: asthma, pneumonia, influenza, tuberculosis, and COVID-19. Systemic lupus erythematosus. Antiphospholipid syndrome. Inherited thrombophilia. Venous thromboembolism and anticoagulation. Hepatitis A. Hepatitis B. Hepatitis C. HIV. Gonorrhea. Chlamydia. Syphilis. Trichomonas. Group B Streptococcus. Vaccination. Trauma. Critical care. Amniotic fluid embolism. Cancer. Dermatoses of pregnancy. Multiple gestations. Fetal growth restriction. Fetal macrosomia. Cytomegalovirus. Toxoplasmosis. Parvovirus. Herpes. Varicella. Fetal and neonatal alloimmune thrombocytopenia. Hemolytic disease of the fetus/neonate. Nonimmune hydrops fetalis. Fetal death. Antepartum testing. Sonographic assessment of amniotic fluid: oligohydramnios and polyhydramnios. OBSTETRIC: Preconception care. Prenatal care. Physiologic changes. Ultrasound. Prenatal diagnosis and screening for aneuploidy. Carrier screening for inherited genetic conditions. Before labor. First stage of labor. Second stage of labor. Third stage of labor. Intrapartum fetal monitoring. Analgesia and anesthesia. Operative vaginal delivery. Cesarean delivery. Trial of labor after caesarean delivery. Early pregnancy loss. Recurrent pregnancy loss. Preterm birth prevention in asymptomatic women. Preterm labor. Preterm premature rupture of membranes. Premature rupture of membranes at or near term. Late term and induction of labor. Intraamniotic infection. Meconium. Malpresentation and malposition. Shoulder dystocia. Postpartum hemorrhage, retained placenta, and uterine inversion. Placental disorders. Abruptio placentae. Postpartum care. The neonate. The adnexal mass. Cervical cancer screening and management in pregnancy.
